Markus Sieger, Director at Cyclo Therapeutics, Inc. (CYTH), bought 59,881 shares at $0.71 ($43K) on 2023-04-20, disclosed to the SEC on 2023-04-24.
Open-market purchase of $43k CYTH by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Clearly above the average filing.
| Filing → |
| CYTH | BUY | 2021-01-27 | $64K | — | Filing → |
| CTDH | BUY | 2020-04-27 | $50K | — | Filing → |
| CTDH | BUY | 2019-08-26 | $22K | — | Filing → |